Washington, D.C. (June 8, 2023) – The Alliance of Community Health Plans (ACHP) is the only national payer group pushing for comprehensive drug pricing reform. Allowing Medicare to negotiate for lower prescription drug prices is an important step toward better health care for all. We reaffirm our support for the Inflation Reduction Act’s critical tools to lower drug prices for millions of Americans. Further, we continue to urge Congress to extend the Inflation Reduction Act drug pricing provisions to the commercial market.
###
About ACHP
The Alliance of Community Health Plans (ACHP) represents the nation’s top-performing nonprofit health companies, which serve tens of millions of Americans in nearly 40 states and D.C. ACHP member plans collaborate with providers on high-quality coverage and care — leading the industry in practical reforms.
ACHP is the voice of a unique payer-provider partnership model advancing proven solutions that deliver better value for patients, employers and taxpayers. Contact us for case studies and data about member innovations and results.
New from ACHP:
- ACHP Recommendations for an Inferred Risk Adjustment Model
- ACHP Members Lead 2027 Star Ratings and NCQA Ratings
- ACHP Urges CMS to Align State Directed Payment Policy With Plans’ Financial Risk
- Strengthening Medicare Advantage in 2028: ACHP Recommendations to CMS
- ACHP Comments on Senate Finance Health Coverage RFI
- Sens. King, Curtis Named ACHP’s 2026 Legislative Champions
